Asked by: Stephen Morgan (Labour - Portsmouth South)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, what steps his Department is taking to tackle (a) fraud and (b) misuse of Lasting Power of Attorney.
Answered by Mike Freer - Parliamentary Under-Secretary (Ministry of Justice)
Under the Mental Capacity Act 2005, execution of a lasting power of attorney (LPA) must be witnessed and a certificate provider must confirm that the donor understands the powers they are conferring on their attorney or attorneys and is not being coerced to make the LPA. A mandatory 4-week period must elapse before registration, allowing time for objections to be raised prior to registration.
Following consultation on ways to strengthen these protections, my department is working with the Office of the Public Guardian to implement a modernised LPA, facilitated by the Powers of Attorney Act 2023.
The modernised LPA will introduce identity checks for donors and certificate providers to reduce the risk that an unknown party could obtain an LPA in another person’s name without their knowledge. The certificate provider will be required to be present at execution of the LPA by the donor and a more streamlined objection process will allow anyone to object, making it easier for potential abuses to be challenged earlier in the process. These measures collectively should reduce the risk of fraudulent LPAs and abuse of the powers they confer.
Once the LPA is registered, any concerns about its use can be reported to the Office of the Public Guardian, which has authority to investigate. It can, if necessary, ask the court to remove the power for an attorney to act.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department for Business and Trade:
To ask His Majesty's Government what recent discussions they have had with the Northern Ireland Executive about the extension of the Post Office (Horizon System) Offences Bill to Northern Ireland.
Answered by Lord Offord of Garvel - Parliamentary Under Secretary of State (Department for Business and Trade)
The Government have decided to extend the territorial extent of the Post Office (Horizon System) Offences Bill to Northern Ireland.
This is the right choice as the Northern Ireland Assembly faces significant and unique challenges to delivering the necessary legislation at an expedited pace following its recent restoration and its public consultation requirements. These challenges posed the risk of a significant delay to justice for postmasters in Northern Ireland.
My hon. friend, the Minister for Enterprise, Markets and Small Business recently met the First Minister, Deputy First Minister and Justice Minister of the Northern Ireland Executive to discuss these matters.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department for Business and Trade:
To ask His Majesty's Government whether they plan to extend the Post Office (Horizon System) Offences Bill to Northern Ireland.
Answered by Lord Offord of Garvel - Parliamentary Under Secretary of State (Department for Business and Trade)
The Government have decided to extend the territorial extent of the Post Office (Horizon System) Offences Bill to Northern Ireland.
This is the right choice as the Northern Ireland Assembly faces significant and unique challenges to delivering the necessary legislation at an expedited pace following its recent restoration and its public consultation requirements. These challenges posed the risk of a significant delay to justice for postmasters in Northern Ireland.
My hon. friend, the Minister for Enterprise, Markets and Small Business recently met the First Minister, Deputy First Minister and Justice Minister of the Northern Ireland Executive to discuss these matters.
Asked by: Charlotte Nichols (Labour - Warrington North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she is taking steps to increase awareness of naloxone.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.
Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.
The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.
The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.
Asked by: Charlotte Nichols (Labour - Warrington North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made a recent assessment of the potential merits of creating a national naloxone programme.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.
Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.
The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.
The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.
Asked by: Charlotte Nichols (Labour - Warrington North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what her planned timetable is for publishing a response to her Department's consultation on Expanding access to naloxone.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.
Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.
The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.
The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.
Asked by: Charlotte Nichols (Labour - Warrington North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the availability of naloxone across England.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.
Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.
The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.
The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.
Asked by: Emma Hardy (Labour - Kingston upon Hull West and Hessle)
Question to the Department for Environment, Food and Rural Affairs:
To ask the Secretary of State for Environment, Food and Rural Affairs, pursuant to the Answer of 16 January 2024 to Question 8811 on Land Drainage, what his expected timetable is for implementing Schedule 3 of the Flood and Water Management Act 2010; and what (a) correspondence and (b) discussions he has had with local authorities on preparing for the implementation.
Answered by Robbie Moore - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
The Government remains firmly committed to delivering standardised sustainable drainage systems in new developments as stated in our Plan for Water (April 2023). A consultation will take place shortly and final implementation decisions will be made on scope, threshold and process.
Defra officials engage with local authority representatives on this issue on a regular basis. We would expect discussions to intensify during and following the upcoming public consultation.
Asked by: Catherine West (Labour - Hornsey and Wood Green)
Question to the Home Office:
To ask the Secretary of State for the Home Department, pursuant to the Answer of 13 November 2023 to Question 359 on Abortion: Demonstrations, what progress his Department has made on implementing safe access zones.
Answered by Chris Philp - Minister of State (Home Office)
The Government recently ran a public consultation on non-statutory guidance to support the introduction of the offence of interference with access to or provision of abortion services, which closed on 22 January. We are now considering the responses received and will publish the final guidance in due course.
We anticipate commencing Section 9 of the Public Order Act 2023 no later than Spring 2024.
Asked by: Kerry McCarthy (Labour - Bristol East)
Question to the Department for Energy Security & Net Zero:
To ask the Secretary of State for Energy Security and Net Zero, which consultations (a) published and (b) inherited by her Department are awaiting a response; and when she plans to publish each of those responses.
Answered by Justin Tomlinson - Minister of State (Department for Energy Security and Net Zero)
The Department for Energy Security and Net Zero has inherited or published 35 consultations, for which a response by the department is still outstanding:
The Department will respond to each in due course.